• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804325-23
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Sepsis (2067)
Event Date 03/21/2022
Event Type  Injury  
Event Description
It was reported that the patient has a history of st elevated myocardial infarction (stemi) and on (b)(6) 2022 a 3.5x23 mm xience skypoint stent was implanted.On (b)(6) 2022 the patient was re-hospitalized due to an acute myocardial infarction and unspecified sepsis.Medication was provided and no additional patient effects were reported.No additional information was provided.
 
Manufacturer Narrative
The stent remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue.The reported patient effects of sepsis and myocardial infarction are listed in the xience skypoint, everolimus eluting coronary stent system (eecss), electronic instructions for use (eifu) as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the reported treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the patient has a history of st elevated myocardial infarction (stemi) and on (b)(6) 2022 a 3.5x23 mm xience skypoint stent was implanted.On (b)(6) 2022 the patient was re-hospitalized due to an acute myocardial infarction and unspecified sepsis.Medication was provided and no additional patient effects were reported.Subsequent to the initially filed report, the following information was provided: the patient was discharged from the initial procedure on (b)(6) 2022 and was discharged from readmission on (b)(6) 2022.No additional treatment was performed other than the medication provided.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15043509
MDR Text Key296077047
Report Number2024168-2022-07824
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233333
UDI-Public08717648233333
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/02/2023
Device Model Number1804325-23
Device Catalogue Number1804325-23
Device Lot Number1083141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/27/2022
Initial Date FDA Received07/18/2022
Supplement Dates Manufacturer Received07/25/2022
Supplement Dates FDA Received08/15/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/03/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability; Hospitalization; Required Intervention;
Patient Age82 YR
Patient SexMale
Patient Weight93 KG
-
-